BioSpace News Archive

Baxter International Inc., a global medtech leader, announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.

Acorda Therapeutics, Inc. announced that the Nasdaq Hearings Panel has granted the Company’s extension request until June 20, 2023 to regain compliance with the Nasdaq’s minimum $1 bid price per share requirement.

Inventiva reported certain preliminary financial results as of and for the year ended December 31, 2022.

Kintara Therapeutics, Inc. (NASDAQ: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal second quarter ended December 31, 2022 and provided a corporate update.

Argentum Medical, a medical device leader and pioneer of silver-plated nylon technology, today announced the strategic combination with BioDerm, a leading provider of disposable medical devices, wound care products and Part B

The Cure Brain Cancer Foundation CEO has announced he will be making the harrowing trek to the South Pole in order to raise awareness and funds for cancer research.

During festivities at the Glaucoma Research Foundation Annual Gala at the Westin St. Francis last week, president and CEO Thomas M. Brunner awarded the 2023 Shaffer Prize for Innovative Glaucoma Research to both Rachel Wang Kuchtey, MD, PhD of Vanderbilt University and Lev Prasov, MD, PhD from the Kellogg Eye Institute, University of Michigan.

Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced that it will report financial results for the fourth quarter and full year of 2022 after the market close on Tuesday, February 28, 2023.

Innovent Biologics, Inc. announces that the first patient with thyroid associated ophthalmopathy has been successfully dosed in the Phase 2 study of IBI311, a recombinant anti-insulin-like growth factor-1 receptor monoclonal antibody.